Bioavailability and pharmacokinetics of the cardioprotecting flavonoid 7-monohydroxyethylrutoside in mice (Englisch)
- Neue Suche nach: Abou El Hassan, M. A. I.
- Neue Suche nach: Kedde, M. A.
- Neue Suche nach: Zwiers, U. T. H.
- Neue Suche nach: Tourn, E.
- Neue Suche nach: Haenen, G. R. M. M.
- Neue Suche nach: Bast, A.
- Neue Suche nach: van der Vijgh, W. J. F.
- Neue Suche nach: Abou El Hassan, M. A. I.
- Neue Suche nach: Kedde, M. A.
- Neue Suche nach: Zwiers, U. T. H.
- Neue Suche nach: Tourn, E.
- Neue Suche nach: Haenen, G. R. M. M.
- Neue Suche nach: Bast, A.
- Neue Suche nach: van der Vijgh, W. J. F.
In:
CANCER CHEMOTHERAPY AND PHARMACOLOGY
;
52
;
371-376
;
2003
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Bioavailability and pharmacokinetics of the cardioprotecting flavonoid 7-monohydroxyethylrutoside in mice
-
Beteiligte:Abou El Hassan, M. A. I. ( Autor:in ) / Kedde, M. A. ( Autor:in ) / Zwiers, U. T. H. ( Autor:in ) / Tourn, E. ( Autor:in ) / Haenen, G. R. M. M. ( Autor:in ) / Bast, A. ( Autor:in ) / van der Vijgh, W. J. F. ( Autor:in )
-
Erschienen in:CANCER CHEMOTHERAPY AND PHARMACOLOGY ; 52 ; 371-376
-
Verlag:
- Neue Suche nach: SPRINGER INTERNATIONAL
-
Erscheinungsdatum:01.01.2003
-
Format / Umfang:6 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 615.58
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 615.58 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 52
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumorsPeters, G. J. / Noordhuis, P. / Van Kuilenburg, A. B. / Schornagel, J. H. / Gall, H. / Turner, S. L. / Swart, M. S. / Voorn, D. / Van Gennip, A. H. / Wanders, J. et al. | 2003
- 13
-
Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trialSantoso, J. T. / Lucci, J. A. / Coleman, R. L. / Schafer, I. / Hannigan, E. V. et al. | 2003
- 19
-
Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trialNiho, S. / Kubota, K. / Goto, K. / Ohmatsu, H. / Matsumoto, T. / Kakinuma, R. / Nishiwaki, Y. et al. | 2003
- 25
-
Pharmacokinetics and tissue distribution of cryptophycin 52 (C-52) epoxide and cryptophycin 55 (C-55) chlorohydrin in mice with subcutaneous tumorsBoinpally, R. R. / Polin, L. / Zhou, S.-L. / Jasti, B. R. / Wiegand, R. A. / White, K. / Kushner, J. / Horwitz, J. P. / Corbett, T. H. / Parchment, R. E. et al. | 2003
- 34
-
A population model of epirubicin pharmacokinetics and application to dosage guidelinesRalph, L. D. / Thomson, A. H. / Dobbs, N. A. / Twelves, C. et al. | 2003
- 41
-
Combined effects of temozolomide and the ribonucleotide reductase inhibitors didox and trimidox in malignant brain tumor cellsFigul, M. / Soling, A. / Dong, H. J. / Chou, T.-C. / Rainov, N. G. et al. | 2003
- 47
-
Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3Hu, X.-M. / Hirano, T. / Oka, K. et al. | 2003
- 59
-
An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasisDandekar, D. S. / Lokeshwar, V. B. / Cevailos-Arellano, E. / Soloway, M. S. / Lokeshwar, B. L. et al. | 2003
- 67
-
Phase I and pharmacokinetic study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancerIchiki, M. / Gohara, R. / Fujiki, R. / Hoashi, S. / Rikimaru, T. / Aizawa, H. et al. | 2003
- 73
-
Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small-cell lung cancerOshita, F. / Yamada, K. / Kato, Y. / Ikehara, M. / Noda, K. / Tanaka, G. / Nomura, I. / Suzuki, R. / Saito, H. et al. | 2003
- 79
-
Pharmacokinetic and pharmacodynamic effects of oral eniluracil, fluorouracil and leucovorin given on a weekly scheduleGuo, X.-D. / Harold, N. / Saif, M. W. / Schuler, B. / Szabo, E. / Hamilton, J. M. / Monahan, B. P. / Quinn, M. G. / Cliatt, J. / Nguyen, D. et al. | 2003
- 86
-
Clinical effects of combination therapy with mitoxantrone, vincristine, and prednisolone in breast cancerKatsumata, K. / Tomioka, H. / Kusama, M. / Aoki, T. / Koyanagi, Y. et al. | 2003
- 89
-
Granisetron: is there a dose-response effect on nausea and vomiting?Minami, M. et al. | 2003
- 99
-
Modelling of ftorafur and 5-fluorouracil pharmacokinetics following oral UFT administration. A population study in 30 patients with advanced breast cancerUrien, S. / Fumoleau, P. / Campone, M. / Kerbrat, P. / Bonneterre, J. / Fargeot, P. / Deporte-Fety, R. et al. | 2003
- 108
-
Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokineticsde Lima Vazquez, V. / Stuart, O. A. / Mohamed, F. / Sugarbaker, P. H. et al. | 2003
- 113
-
A retrospective evaluation of the feasibility of intrapatient dose escalation as appropriate methodology for dose-ranging studies for combination cytotoxic regimensJordan, S. D. / Poole, C. J. / Archer, V. R. / Steven, N. M. / Burton, A. et al. | 2003
- 119
-
A phase I trial of weekly paclitaxel, 13-cis-retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignanciesThalasila, A. / Poplin, E. / Shih, J. / Dvorzhinski, D. / Capanna, T. / Doyle-Lindrud, S. / Beers, S. / Goodin, S. / Rubin, E. / DiPaola, R. S. et al. | 2003
- 125
-
Phase II study of biweekly irinotecan and mitomycin C combination therapy in patients with fluoropyrimidine-resistant advanced colorectal cancerYamada, Y. / Shirao, K. / Hyodo, I. / Arai, Y. / Denda, T. / Ambo, T. / Ohtsu, A. et al. | 2003
- 131
-
Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studiesMeco, D. / Colombo, T. / Ubezio, P. / Zucchetti, M. / Zaffaroni, M. / Riccardi, A. / Faircloth, G. / Jose, J. / D Incalci, M. / Riccardi, R. et al. | 2003
- 139
-
Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 ratsMusser, S. M. / Egorin, M. J. / Zuhowski, E. G. / Hamburger, D. R. / Parise, R. A. / Covey, J. M. / White, K. D. / Eiseman, J. L. et al. | 2003
- 147
-
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II studyDonadio, M. / Ardine, M. / Berruti, A. / Ritorto, G. / Fea, E. / Mistrangelo, M. / Coccorullo, Z. / Bergnolo, P. / Comandone, A. / Bertetto, O. et al. | 2003
- 153
-
Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group studySoo, R. A. / Lim, H. L. / Wang, L. Z. / Lee, H. S. / Millward, M. J. / Tok, L. T. / Lee, S. C. / Lehnert, M. / Goh, B. C. et al. | 2003
- 159
-
Analysis of docetaxel pharmacokinetics in humans with the inclusion of later sampling time-points afforded by the use of a sensitive tandem LCMS assayGustafson, D. L. / Long, M. E. / Zirrolli, J. A. / Duncan, M. W. / Holden, S. N. / Pierson, A. S. / Eckhardt, S. G. et al. | 2003
- 167
-
Metabolism of dexrazoxane (ICRF-187) used as a rescue agentin cancer patients treated with high-dose etoposideSchroeder, P. E. / Jensen, P. B. / Sehested, M. / Hofland, K. F. / Langer, S. W. / Hasinoff, B. B. et al. | 2003
- 175
-
The topoisomerase I inhibitor topotecan increases the sensitivity of prostate tumor cells to TRAIL/Apo-2L-induced apoptosisGriffith, T. S. / Kemp, T. J. et al. | 2003
- 185
-
Role of mismatch repair in the induction of chromosomal aberrations and sister chromatid exchanges in cells treated with different chemotherapeutic agentsVernole, P. / Pepponi, R. / D Atri, S. et al. | 2003
- 193
-
Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancerReigner, B. / Watanabe, T. / Schuller, J. / Lucraft, H. / Sasaki, Y. / Bridgewater, J. / Saeki, T. / McAleer, J. / Kuranami, M. / Poole, C. et al. | 2003
- 202
-
Peptides designed from molecular modeling studies of the ras-p21 protein induce phenotypic reversion of a pancreatic carcinoma cell line but have no effect on normal pancreatic acinar cell growthKanovsky, M. / Michl, J. / Botzolaki, G. / Morin, J. / Kovac, C. / Chung, D. L. / Chie, L. / Friedman, F. K. / Pincus, M. R. et al. | 2003
- 209
-
Population pharmacokinetics of oral busulfan in childrenSchiltmeyer, B. / Klingebiel, T. / Schwab, M. / Murdter, T. E. / Ritter, C. A. / Jenke, A. / Ehninger, G. / Gruhn, B. / Wurthwein, G. / Boos, J. et al. | 2003
- 217
-
Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancyFlaherty, K. T. / Stevenson, J. P. / Hahn, S. M. / Redlinger, M. / O Dwyer, P. J. et al. | 2003
- 223
-
Amifostine does not reduce the toxicity of the fludarabine and cyclophosphamide regimen in patients with chronic lymphocytic leukemiaGiles, F. J. / Shi, G. G. / Cortes, J. E. / Thomas, D. / Keating, A. R. / Kantarjian, H. M. / Keating, M. J. / O Brien, S. M. et al. | 2003
- 229
-
Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disordersTsimberidou, A. M. / Colburn, D. E. / Welch, M. A. / Cortes, J. E. / Verstovsek, S. / O Brien, S. M. / Albitar, M. / Kantarjian, H. M. / Giles, F. J. et al. | 2003
- 235
-
Sensitization of human breast cancer cells to gemcitabine by the protein kinase C modulator bryostatin 1Ali, S. / Aranha, O. / Li, Y. / Pettit, G. R. / Sarkar, F. H. / Philip, P. A. et al. | 2003
- 247
-
Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancerFeliu, J. / Martin, G. / Madronal, C. / Rodriguez-Jaraiz, A. / Castro, J. / Rodriguez, A. / Checa, T. / Bolano, M. / Casado, E. / Gonzalez-Baron, M. et al. | 2003
- 253
-
The activity of camptothecin analogues is enhanced in histocultures of human tumors and human tumor xenografts by modulation of extracellular pHFlowers, J. L. / Hoffman, R. M. / Driscoll, T. A. / Wall, M. E. / Wani, M. C. / Manikumar, G. / Friedman, H. S. / Dewhirst, M. / Colvin, O. M. / Adams, D. J. et al. | 2003
- 263
-
Myofibroblasts enable invasion of endothelial cells into three-dimensional tumor cell clusters: a novel in vitro tumor modelWalter-Yohrling, J. / Pratt, B. M. / Ledbetter, S. / Teicher, B. A. et al. | 2003
- 270
-
Targeting of a novel fusion protein containing methioninase to the urokinase receptor to inhibit breast cancer cell migration and proliferationPeron, K. / Jones, T. N. / Gauthier, S. A. / Nguyen, T.-N. T. / Zang, X.-P. / Barriere, M. / Preveraud, D. / Soliman, C. E. / Harrison, R. G. / Pento, J. T. et al. | 2003
- 277
-
A phase I study of ZD0473 combined with paclitaxel for the treatment of solid malignanciesTwelves, C. / Reck, M. / Anthoney, A. / Gatzemeier, U. / Kaye, S. et al. | 2003
- 282
-
Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimenYchou, M. / Duffour, J. / Kramar, A. / Debrigode, C. / Gourgou, S. / Bressolle, F. / Pinguet, F. et al. | 2003
- 291
-
Selective enhancement of ifosfamide-induced toxicity in Chinese hamster ovary cellsSmith, S. M. / Ludeman, S. M. / Wilson, L. R. / Springer, J. B. / Gandhi, M. C. / Dolan, M. E. et al. | 2003
- 303
-
Phase II study of docetaxel and topotecan combination chemotherapy in patients with advanced head and neck cancerHaddad, R. I. / Van Echo, D. A. et al. | 2003
- 307
-
Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell linesAvramis, I. A. / Laug, W. E. / Sausville, E. A. / Avramis, V. I. et al. | 2003
- 319
-
Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanomaNakajima, M. / Hayashi, K. / Egi, Y. / Katayama, K.-i. / Amano, Y. / Uehata, M. / Ohtsuki, M. / Fujii, A. / Oshita, K.-i. / Kataoka, H. et al. | 2003
- 325
-
The role of DNA synthesis inhibition in the cytotoxicity of 2',2'-difluoro-2'-deoxycytidineOstruszka, L. J. / Shewach, D. S. et al. | 2003
- 333
-
A phase I study of 9-aminocamptothecin as a colloidal dispersion formulation given as a fortnightly 72-h infusionLeguizamo, J. / Quinn, M. / Takimoto, C. H. / Liang, M. D. / Ismail, A.-S. A. / Pang, J. / Dahut, W. / Grem, J. L. et al. | 2003
- 339
-
A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancerReina, J. J. / Aparicio, J. / Salvador, J. / Pica, J. M. P. / Rueda, A. / Lorenzo, A. / de la Puente, C. G. / Borrega, P. / Moreno-Nogueira, J. A. et al. | 2003
- 346
-
Equivalent single-dose pharmacokinetics of two different dosing methods of prolonged-release fulvestrant (`Faslodex') in postmenopausal women with advanced breast cancerRobertson, J. F. R. / Harrison, M. P. et al. | 2003
- 349
-
Alleviation of side effects induced by irinotecan hydrochloride (CPT-11) in rats by intravenous infusionKurita, A. / Kado, S. / Kaneda, N. / Onoue, M. / Hashimoto, S. / Yokokura, T. et al. | 2003
- 361
-
Phase I trial of perillyl alcohol administered four times daily continuouslyMorgan-Meadows, S. / Dubey, S. / Gould, M. / Tutsch, K. / Marnocha, R. / Arzoomanin, R. / Alberti, D. / Binger, K. / Feierabend, C. / Volkman, J. et al. | 2003
- 367
-
Reversibility of liver failure secondary to metastatic breast cancer by vinorelbine and cisplatin chemotherapySharma, R. A. / Decatris, M. P. / Santhanam, S. / Roy, R. / Osman, A. E. / Clarke, C. B. / Khanna, S. / O Byrne, K. J. et al. | 2003
- 371
-
Bioavailability and pharmacokinetics of the cardioprotecting flavonoid 7-monohydroxyethylrutoside in miceAbou El Hassan, M. A. I. / Kedde, M. A. / Zwiers, U. T. H. / Tourn, E. / Haenen, G. R. M. M. / Bast, A. / van der Vijgh, W. J. F. et al. | 2003
- 377
-
Metronomic oral low-dose treosulfan chemotherapy combined with cyclooxygenase-2 inhibitor in pretreated advanced melanoma: a pilot studySpieth, K. / Kaufmann, R. / Gille, J. et al. | 2003
- 383
-
Induction of the PAOh1/SMO polyamine oxidase by polyamine analogues in human lung carcinoma cellsDevereux, W. / Wang, Y. / Stewart, T. M. / Hacker, A. / Smith, R. / Frydman, B. / Valasinas, A. L. / Reddy, V. K. / Marton, L. I. / Ward, T. D. et al. | 2003
- 391
-
Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cellsNiiya, M. / Niiya, K. / Kiguchi, T. / Shibakura, M. / Asaumi, N. / Shinagawa, K. / Ishimaru, F. / Kiura, K. / Ikeda, K. / Ueoka, H. et al. | 2003
- 399
-
Dihydropyrimidine dehydrogenase (DPD) rapidly regenerates after inactivation by eniluracil (GW776C85) in primary and metastatic colorectal cancerHeslin, M. J. / Yan, J. / Weiss, H. / Shao, L. / Owens, J. / Lucas, V. S. / Diasio, R. B. et al. | 2003
- 405
-
Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutionsMohamed, F. / Marchettini, P. / Stuart, O. A. / Sugarbaker, P. H. et al. | 2003
- 411
-
New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicityEl-Demerdash, E. / Ali, A. A. / Sayed-Ahmed, M. M. / Osman, A.-M. M. et al. | 2003
- 417
-
Pharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancerThompson, P. / Balis, F. / Serabe, B. M. / Berg, S. / Adamson, P. / Klenke, R. / Aiken, A. / Packer, R. / Murry, D. J. / Jakacki, R. et al. | 2003
- 424
-
Assessment of normal and tumor tissue uptake of MAG-CPT,a polymer-bound prodrug of camptothecin, in patients undergoing elective surgery for colorectal carcinomaSarapa, N. / Britto, M. R. / Speed, W. / Jannuzzo, M. / Breda, M. / James, C. A. / Porro, M. / Rocchetti, M. / Wanders, A. / Mahteme, H. et al. | 2003
- 431
-
Cardiac troponin T as an indicator of reduced left ventricular contractility in experimental anthracycline-induced cardiomyopathySimunek, T. / Klimtova, I. / Adamcova, M. / Gersl, V. / Hrdina, R. / Sterba, M. / Kaplanova, J. / Mazurova, Y. et al. | 2003
- 435
-
Population pharmacokinetics of temozolomide and metabolites in infants and children with primary central nervous system tumorsPanetta, J. C. / Kirstein, M. N. / Gajjar, A. / Nair, G. / Fouladi, M. / Heideman, R. L. / Wilkinson, M. / Stewart, C. F. et al. | 2003
- 442
-
The effect of gefitinib (Iressa, ZD1839) in combination with oxaliplatin is schedule-dependent in colon cancer cell linesXu, J.-M. / Azzariti, A. / Colucci, G. / Paradiso, A. et al. | 2003
- 449
-
Mylotarg, fludarabine, cytarabine (ara-C), and cyclosporine (MFAC) regimen as post-remission therapy in acute myelogenous leukemiaTsimberidou, A. M. / Estey, E. / Cortes, J. E. / Garcia-Manero, G. / Faderl, S. / Verstovsek, S. / Thomas, D. A. / Ferrajoli, A. / Keating, M. J. / O Brien, S. et al. | 2003
- 453
-
Scutellaria baicalensis extract decreases cisplatin-induced pica in ratsAung, H. H. / Dey, L. / Mehendale, S. / Xie, J.-T. / Wu, J. A. / Yuan, C.-S. et al. | 2003
- 459
-
Pharmacokinetics of temozolomide given three times a day in pediatric and adult patientsRiccardi, A. / Mazzarella, G. / Cefalo, G. / Garre, M. L. / Massimino, M. / Barone, C. / Sandri, A. / Ridola, V. / Ruggiero, A. / Mastrangelo, S. et al. | 2003
- 465
-
Second-line chemotherapy with low-dose CPT-11 and cisplatin for colorectal cancer resistant to 5-FU-based chemotherapyYoshimatsu, K. / Kato, H. / Ishibashi, K. / Hashimoto, M. / Umehara, A. / Yokomizo, H. / Yoshida, K. / Fujimoto, T. / Iwasaki, K. / Ogawa, K. et al. | 2003
- 469
-
Dihydropyrimidine dehydrogenase and thymidylate synthase activities in hepatocellular carcinomas and in diseased liversBaba, H. / Teramoto, K. / Kawamura, T. / Mori, A. / Imamura, M. / Arii, S. et al. | 2003
- 477
-
Dexrazoxane's protection of jejunal crypt cells in the jejunum of C3Hf/Kam mice from doxorubicin-induced toxicityPearlman, M. / Jendiroba, D. / Pagliaro, L. / Keyhani, A. / Liu, B. / Freireich, E. J. / Travis, E. et al. | 2003
- 482
-
Acute effects of megestrol on the hypothalamic-pituitary-adrenal axisRaedler, T. J. / Jahn, H. / Goedeken, B. / Gescher, D. M. / Kellner, M. / Wiedemann, K. et al. | 2003
- 487
-
A phase I and pharmacologic study of weekly gemcitabine in combination with infusional 5-fluorodeoxyuridine and oral calcium leucovorinGrem, J. L. / Quinn, M. G. / Keith, B. / Monahan, B. P. / Hamilton, J. M. / Xu, Y. / Harold, N. / Nguyen, D. / Takimoto, C. H. / Rowedder, A. et al. | 2003
- 497
-
Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cellsBouffard, D. Y. / Jolivet, J. / Leblond, L. / Hamelin, B. / Ouellet, F. / Barbeau, S. / Richard, A. / Gourdeau, H. et al. | 2003
- 507
-
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment timeGermani, M. / Magni, P. / De Nicolao, G. / Poggesi, I. / Marsiglio, A. / Ballinari, D. / Rocchetti, M. et al. | 2003
- 514
-
Two different schedules of irinotecan (CPT-11) in patients with advanced colorectal carcinoma relapsing after a 5-fluorouracil and leucovorin combination. A randomized studyTsavaris, N. / Ziras, N. / Kosmas, C. / Giannakakis, T. / Gouveris, P. / Vadiaka, M. / Dimitrakopoulos, A. / Karadima, D. / Rokana, S. / Papalambros, E. et al. | 2003
- S3
-
New approaches to drug discovery and development: a mechanism-based approach to pharmaceutical research and its application to BNP7787, a novel chemoprotective agentHausheer, F. H. / Kochat, H. / Parker, A. R. / Ding, D. / Yao, S. / Hamilton, S. E. / Petluru, P. N. / Leverett, B. D. / Bain, S. H. / Saxe, J. D. et al. | 2003
- S16
-
Structural development of synthetic retinoids and thalidomide-related moleculesHashimoto, Y. et al. | 2003
- S24
-
Survival-signaling pathway as a promising target for cancer chemotherapyFujita, N. / Tsuruo, T. et al. | 2003
- S29
-
Anticancer drug development at the US National Cancer InstituteTakimoto, C. H. et al. | 2003
- S34
-
Clinical significance of the expression of estrogen receptors alpha and beta for endocrine therapy of breast cancerIwase, H. / Zhang, Z. / Omoto, Y. / Sugiura, H. / Yamashita, H. / Toyama, T. / Iwata, H. / Kobayashi, S. et al. | 2003
- S39
-
New approaches to the endocrine prevention and treatment of breast cancerHowell, A. / Howell, S. J. / Evans, D. G. et al. | 2003
- S45
-
The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperonesWorkman, P. et al. | 2003
- S57
-
Pharmacogenomic applications in clinical drug developmentDracopoli, N. C. et al. | 2003
- S61
-
Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasmsSenderowicz, A. M. et al. | 2003
- S74
-
Panel of human cancer cell lines provides valuable database for drug discovery and bioinformaticsYamori, T. et al. | 2003
- S80
-
Thymidylate synthase inhibitors as anticancer agents: from bench to bedsideChu, E. / Callender, M. A. / Farrell, M. P. / Schmitz, J. C. et al. | 2003
- S90
-
Monoclonal antibodies for the treatment of hematologic malignancies: clinical trials in JapanTobinai, K. et al. | 2003
- S97
-
Strategy for the development of novel anticancer drugsSaijo, N. / Tamura, T. / Nishio, K. et al. | 2003